Moneycontrol
Get App
Last Updated : Nov 13, 2018 05:01 PM IST | Source: Moneycontrol.com

Parenteral Drug Standalone September 2018 Net Sales at Rs 8.90 crore, down 19.66% Q-o-Q

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Reported Standalone quarterly numbers for Parenteral Drugs (India) are:

Net Sales at Rs 8.90 crore in September 2018 down 19.66% from Rs. 11.08 crore in September 2017.

Quarterly Net Loss at Rs. 26.86 crore in September 2018 down 18.28% from Rs. 22.71 crore in September 2017.

Close

EBITDA stands negative at Rs. 3.84 crore in September 2018 down 61.34% from Rs. 2.38 crore in September 2017.

Parenteral Drug shares closed at 8.90 on November 12, 2018 (NSE) and has given -25.83% returns over the last 6 months and -50.14% over the last 12 months.

Parenteral Drugs (India)
Standalone Quarterly Resultsin Rs. Cr.
Sep'18Jun'18Sep'17
Net Sales/Income from operations8.8910.5610.82
Other Operating Income0.010.020.26
Total Income From Operations8.9010.5911.08
EXPENDITURE
Consumption of Raw Materials2.811.961.50
Purchase of Traded Goods----0.39
Increase/Decrease in Stocks-0.76-0.47-0.72
Power & Fuel------
Employees Cost4.904.983.04
Depreciation4.634.654.53
Excise Duty------
Admin. And Selling Expenses------
R & D Expenses------
Provisions And Contingencies------
Exp. Capitalised------
Other Expenses5.786.379.26
P/L Before Other Inc. , Int., Excpt. Items & Tax-8.47-6.91-6.91
Other Income------
P/L Before Int., Excpt. Items & Tax-8.47-6.91-6.91
Interest23.8622.8522.15
P/L Before Exceptional Items & Tax-32.33-29.76-29.06
Exceptional Items------
P/L Before Tax-32.33-29.76-29.06
Tax-5.47-5.92-6.35
P/L After Tax from Ordinary Activities-26.86-23.84-22.71
Prior Year Adjustments------
Extra Ordinary Items------
Net Profit/(Loss) For the Period-26.86-23.84-22.71
Equity Share Capital29.8229.8229.82
Reserves Excluding Revaluation Reserves------
Equity Dividend Rate (%)------
EPS Before Extra Ordinary
Basic EPS-9.01-8.00-7.62
Diluted EPS-9.01-8.00-7.62
EPS After Extra Ordinary
Basic EPS-9.01-8.00-7.62
Diluted EPS-9.01-8.00-7.62
Public Share Holding
No Of Shares (Crores)------
Share Holding (%)------
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
b) Non-encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
Source : Dion Global Solutions Limited



Exclusive offer: Use code "BUDGET2020" and get Moneycontrol Pro's Subscription for as little as Rs 333/- for the first year.
First Published on Nov 13, 2018 04:55 pm
Sections
Follow us on